who we are

We are in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, we have established strong relationships with leading global generic pharmaceutical companies that have helped us expand our product offerings and geographic reach. We work with 16 of the 20 largest generic companies globally. (Source: A Year of Surprises Shakes Up Off-Patent Industryā€¯ | Informa, 2020)

With 142 APIs in our portfolio, we are blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality.

Powered by our massive, world-class manufacturing and research capabilities, we supply high-quality APIs to more than 700 pharma companies in multiple countries.